Unosi

• Učestalost faktora rizika za aterosklerozu u odnosu na pol kod radno sposobnih osoba u opštini Gradiška (2005)

  B. Mirjanić-Azarić, S. Rodić, M. Đerić, Učestalost faktora rizika za aterosklerozu u odnosu na pol kod radno sposobnih osoba u opštini Gradiška, SCRIPTA MEDICA, Vol. 36, pp. 37 - 42, 2005

• Lipidski status u korelaciji sa životnim navikama (2006)

  B. Mirjanić-Azarić, M. Đerić, M. Vrhovac, D. Šukalo, Lipidski status u korelaciji sa životnim navikama, MEDICINSKI PREGLED, Vol. 59, pp. 57 - 62, 2006

• Nivo C-reaktivnog proteina i HDL-holesterola kod pacijenata sa sumnjom na akutni infarkt miokarda neposredno po prijemu u internističku ambulantu (2007)

  B. Mirjanić-Azarić, S. Avram, D. Trninić, N. Rašeta, Nivo C-reaktivnog proteina i HDL-holesterola kod pacijenata sa sumnjom na akutni infarkt miokarda neposredno po prijemu u internističku ambulantu, SCRIPTA MEDICA, Vol. 38, pp. 65 - 70, 2007

• Povezanost nivoa C-reaktivnog proteina sa vodećim faktorima rizika kardiovaskularnih bolesti kod muškaraca (2008)

  B. Mirjanić-Azarić, M. Đerić, M. Vrhovac, L. Maleš-Bilić, Povezanost nivoa C-reaktivnog proteina sa vodećim faktorima rizika kardiovaskularnih bolesti kod muškaraca, MEDICINSKI PREGLED, Vol. 61, pp. 164 - 168, 2008

• Atorvastatin in stable angina patients lowers CCL2 and ICAM1 expression: pleiotropic evidence from plasma mRNA analyses (2013)

  B. Mirjanić-Azarić, M. Rizzo, Lj. Sormaz, D. Stojanović, S. Uletilović, S. Sodin, Atorvastatin in stable angina patients lowers CCL2 and ICAM1 expression: pleiotropic evidence from plasma mRNA analyses, CLINICAL BIOCHEMISTRY, Vol. 46, pp. 1526 - 1531, 2013

• Atorvastatin in stable angina patients lowers CCL2 and ICAM1 expression: Pleiotropic evidence from plasma mRNA analyses (2013)

  B. Mirjanic-Azaric, M. Rizzo, L. Sormaz, D. Stojanovic, S. Uletilović, S. Sodin-Semrl, K. Lakota, A. Artenjak, J. Marc, D. Cerne, Atorvastatin in stable angina patients lowers CCL2 and ICAM1 expression: Pleiotropic evidence from plasma mRNA analyses, CLINICAL BIOCHEMISTRY, Vol. 46, pp. 1526 - 1531, 2013

• Interrelated cathepsin S-lowering and LDL subclass profile improvements induced by atorvastatin in the plasma of stable angina patients. (2014)

  B. Mirjanic-Azaric, J. Vekic, A. Zeljkovic, Z. Jelic-Ivanovic, M. Djeric, T. Milivojac, U. Pecar Fonovic, J. Marc, J. Kos, D. Cerne, Interrelated cathepsin S-lowering and LDL subclass profile improvements induced by atorvastatin in the plasma of stable angina patients., JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, Vol. 21, pp. 868 - 877, 2014

• Atorvastatin pleiotropic effects on stable angina patients: evidence by analysis of high-density lipoprotein size and subclasses, and plasma mRNA. (2015)

  B. Mirjanic-Azaric, Z. Jelic-Ivanovic, A. Zeljkovic, J. Vekic, G. Jurgens, T. Milivojac, S. Avram, J. Coric, J. Marc, D. Cerne, Atorvastatin pleiotropic effects on stable angina patients: evidence by analysis of high-density lipoprotein size and subclasses, and plasma mRNA., JOURNAL OF MEDICAL BIOCHEMISTRY, Vol. 34, pp. 314 - 322, 2015

• Atorvastatin treatment increases plasma bilirubin but not HMOX1 expression in stable angina patients. (2015)

  B. Mirjanic-Azaric, M. Rizzo, G. Jurgens, S. Hallstroem, s. Srdic, J. Marc, D. Cerne, Atorvastatin treatment increases plasma bilirubin but not HMOX1 expression in stable angina patients., SCANDINAVIAN JOURNAL OF CLINICAL AND LABORATORY INVESTIGATION, Vol. 75, pp. 382 - 389, 2015

• The impact of time of sample collection on the measurement of thyroid stimulating hormone values in the serum. (2015)

  B. Mirjanic-Azaric, T. Stojakovic-Jelisavac, B. Vukovic, D. Stojanovic, M. Vujnic, S. Uletilovic, The impact of time of sample collection on the measurement of thyroid stimulating hormone values in the serum., CLINICAL BIOCHEMISTRY, Vol. 48, pp. 1347 - 1349, 2015

• Direct estimation of reference intervals for thyroid parameters in the Rebublic of Srpska (2017-03)

  B. Mirjanić-Azarić, S. Avram, T. Stojakovic-Jelisavac, D. Stojanovic, M. Petkovic, N. Bogavac-Stanojevic, S. Ignjatovic, M. Stojanov, Direct estimation of reference intervals for thyroid parameters in the Rebublic of Srpska, JOURNAL OF MEDICAL BIOCHEMISTRY, Vol. 36, No. 2, pp. 137 - 144, Mar, 2017

• Plasma Cathepsin S is Associated with High-density Lipoprotein Cholesterol and Bilirubin in Patients with Abdominal Aortic Aneurysms. (2019-05)

  B. Mirjanić-Azarić, N. Vasić, D. Cerne, J. Kos, N. Bogavac-Stanojevic, Plasma Cathepsin S is Associated with High-density Lipoprotein Cholesterol and Bilirubin in Patients with Abdominal Aortic Aneurysms., JOURNAL OF MEDICAL BIOCHEMISTRY, Vol. 38, No. 3, pp. 268 - 275, May, 2019

• Indirect estimation of reference intervals for thyroid parameters using ADVIA Centaur XP analyzer. (2022-04)

  B. Mirjanić-Azarić, N. Milinkovic, N. Bogavac-Stanojevic, S. Avram, T. Stojakovic-Jelisavac, D. Stojanovic, Indirect estimation of reference intervals for thyroid parameters using ADVIA Centaur XP analyzer., JOURNAL OF MEDICAL BIOCHEMISTRY, Vol. 41, No. 2, pp. 238 - 245, Apr, 2022

• Lipidni status skupine radno sposobnih ispitanika (2003-09)

  B. Mirjanić-Azarić, M. Đerić, M. Popović, Ž. Saničanin, Lipidni status skupine radno sposobnih ispitanika, Biochemia Medica 2003; 13 (Prilog br.1-2):78(P3-16), Sep, 2003

• Lipid status of working capable population in Gradiška municipability in correlation with body mass. (2004-06)

  B. Mirjanić-Azarić, M. Đerić, M. Vrhovac, S. Uletilovic, B. Ilić, Lipid status of working capable population in Gradiška municipability in correlation with body mass., Jugoslov Med Biohem 2004; 23 (suppl 3):90, Jun, 2004

• Helicobacter pylori seroprevalence in patients with upper digestive tract symptoms in Banjaluka area (2004-09)

  M. Vrhovac, B. Mirjanić-Azarić, M. Novaković, G. Turjačanin, Helicobacter pylori seroprevalence in patients with upper digestive tract symptoms in Banjaluka area, Blackwell Publishing Ltd, Helicobacter, 2004; 9: 487–604.N, Sep, 2004

• Prikaz vodećih prediktivnih faktora za nastanak kardiovaskularnih bolesti kod radno sposobnih muškaraca. (2006-10)

  B. Mirjanić-Azarić, M. Đerić, M. Vrhovac, M. Popović, Prikaz vodećih prediktivnih faktora za nastanak kardiovaskularnih bolesti kod radno sposobnih muškaraca., Jugoslov Med Biohemija 2006; 25 (4): 479., Oct, 2006

• Nivo C-reaktivnog proteina neposredno po prijemu u internističku ambulantu kod pacijenata kod kojih se sumnja na infarkt miokarda. (2008-06)

  B. Mirjanić-Azarić, M. Đerić, S. Avram, N. Rašeta, Nivo C-reaktivnog proteina neposredno po prijemu u internističku ambulantu kod pacijenata kod kojih se sumnja na infarkt miokarda., Jugoslov Med Biohemija 2008; 27 (2): 229-230., Jun, 2008

• Optimisation of methods for isolation and quantification of plasma mRNA HMOX-1 in patients with stable angina. (2012)

  B. Mirjanic-Azaric, D. Stojanovic, S. Avram, D. Cerne, Optimisation of methods for isolation and quantification of plasma mRNA HMOX-1 in patients with stable angina., 2012

• Results screening test first trimester of pregnancy and prenatal diagnostics karyotype in Banja Luka Clinical Center (2013-05)

  A. Đorđević, B. Mirjanić-Azarić, R. Malešević, J. Miljuš, Results screening test first trimester of pregnancy and prenatal diagnostics karyotype in Banja Luka Clinical Center, Biochimica Clinica, 2013;37, SS, S396., May, 2013